FCC ID: 2AYOH-CZ-B801 Rechargeable OTC Hearing Aids

The product does not have enough space to place the label, FCC ID and the 15.19 warning statement are located in the user manual and package. User manual and package as below:

Label Location

Cemho Medical Technology (Guangdong) Co., Ltd Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 USA Date: 09-14-2026 Ref: Attestation Statements Part 2.911(d)(5)(i) and Part 2.911(d)(5)(ii) FCC ID: 2AYOH-CZ-B801 Part 2.911(d)(5)(i)

[Cemho Medical Technology (Guangdong) Co., Ltd] (the applicant) certifies that the equipment for which authorization is sought is not covered equipment and does not contain anti-virus software or cybersecurity software prohibited from receiving an equipment authorization pursuant to 47 CFR 2.903, KDB 986446 D01 Covered Equipment Guidance, and FCC Covered List

(www.fcc.gov/supplychain/coveredlist). Part 2.911(d)(5)(ii)

[Cemho Medical Technology (Guangdong) Co., Ltd] (the applicant) certifies that, as of the date of the filing of the application, the applicant is not identified on the Covered List (as a specifically named entity or any of its subsidiaries or affiliates) as an entity producing covered equipment. Sincerely,

(Applicant signature)

(Cassart HONG) Rev 2026-04-24

Cemho Medical Technology (Guangdong) Co., Ltd Federal Communications Commission Authorization and Evaluation Division 7435 Oakland Mills Road Columbia, MD 21046 Date: 09-14-2026 SUBJECT: FCC Application for FCC ID: 2AYOH-CZ-B801 To Whom It May Concern:

We, the undersigned, hereby authorize Max Zhang at Shenzhen Tongzhou Testing Co.,Ltd. on our behalf, to apply to the Federal Communications Commission on our equipment. Any and all acts carried out by Shenzhen Tongzhou Testing Co.,Ltd. on our behalf shall have the same effect as acts of our own. This is to advise that we are in full compliance with the Anti- Drug Abuse Act. We, the applicant, are not subject to a denial of federal benefits pursuant to Section 5301 of the Anti-Drug Act of 1988, 21 USC853a, and no party to the application is subject to a denial of federal benefits pursuant to that section. Regards,

(Cassart HONG)

Cemho Medical Technology (Guangdong) Co., Ltd. Federal Communications Commission Authorization and Evaluation Division Date: 09-14-2026 Confidentiality Request regarding application for certification of FCC ID: 2AYOH-CZ-B801 Pursuant to Sections 0.457 and 0.459 of the Commissions Rules, we hereby request confidential treatment of information accompanying this application as outlined below:

Exhibit Type Block Diagram, Schematics, Operational Description File Name*

Block.pdf, SCH.pdf, Operation description-

BT.pdf The above materials contain trade secrets and proprietary information not customarily released to the public. The public disclosure of these materials may be harmful to the applicant and provide unjustified benefits to its competitors. The applicant understands that pursuant to Section 0.457 of the Rules, disclosure of this application and all accompanying documentation will not be made before the date of the Grant for this application. Pursuant to DA04-1705 June 15, 2004 of the Commissions public notice, we also request 180 days temporary confidential treatment of information accompanying this application as outlined below:

Exhibit Type

(External Photos, Internal Photos, Test Setup Photos, User Manual) File Name*

(External photos.pdf, Internal Photos.pdf, Test Setup Photos.pdf, User Manual.pdf) Sincerely,

(signature)

(Cassart HONG) Rev 11/20/07

Cemho Medical Technology (Guangdong) Co., Ltd Cemho Medical Industrial Park, West of Xinghe Line, Dongguan Shijie (Xingning) Industrial Transfer Industrial Park, Xingning, 514500 Meizhou, Guangdong, China Date: 09-14-2026 Dear Sir/Madam, Product Name: Rechargeable OTC Hearing Aids FCC ID: 2AYOH-CZ-B801 Model no.: CZ-B801, CZ-B802, CZ-B803, CZ-B805, CZ-B807, CZ-B808, CZ-B809, CZ-B810, CZ-

B811, CZ-B812, CZ-B813, CZ-B815 We, Cemho Medical Technology (Guangdong) Co., Ltd, Hereby declares the following statement, PCB board, circuit, structure and internal of these model(s) are the same, except for the model name. Sincerely,

#SigApplicant Name/Title Cassart HONG / Manager

Cemho Medical Technology (Guangdong) Co., Ltd Cemho Medical Industrial Park, West of Xinghe Line, Dongguan Shijie (Xingning) Industrial Transfer Industrial Park, Xingning, 514500 Meizhou, Guangdong, China Federal Communications Commission Authorization and Evaluation Division Equipment Authorization Branch 7435 Oakland Mills Road Columbia, MD 21046 U.S. Agent Designation Date: Sep. 10, 2026 Cemho Medical Technology (Guangdong) Co., Ltd acknowledges their consent for the following contact located in the United States to act as their agent for service of process for the equipment for which authorization is sought

(FCC ID: 2AYOH-CZ-B801) Name and company of U.S. agent: GLOCERTS TECHNOLOGY INC Physical U.S. address of agent: 19784 SUNKISSED RIDGE DR, RIVERSIDE, CA 92507 FRN of U.S. agent: 0036339737 Email address of U.S. agent: [email protected] Telephone of U.S.agent: (626) 588-8039 GLOCERTS TECHNOLOGY INC acknowledges their obligation to accept service of process on behalf of Cemho Medical Technology (Guangdong) Co., Ltd. Cemho Medical Technology (Guangdong) Co., Ltd. with the FRN [0030398127] accepts its obligation to maintain an agent for service of process in the United States for no less than 1 year after either the grantee has permanently terminated all marketing and importation of the applicable equipment within the U.S., or the conclusion of any Commission-related administrative or judicial proceeding involving the equipment, whichever is later. By signing this form, we confirm the above and that we are aware of the application requirements listed under 2.911(d)(7). The information provided in this letter is based on the referenced rule parts of Title 47 of the CFR as well as KDB 986446 D01. An expiration date for this letter does not exist. In case the U.S. agent changes, the grantee is obligated to notify the FCC within 30 days via the granting TCB. Sincerely, Signature Cassart HONG Manager Signature Huiying Fan Director Cemho Medical Technology (Guangdong) GLOCERTS TECHNOLOGY INC Co., Ltd The information provided in this letter is based on the referenced rule parts of Title 47 of the CFR as well as KDB 986446 D01. An expiration date for this letter does not exist. In case the U.S. agent changes, the grantee is obligated to notify the FCC within 30 days via the granting TCB. 5 0 V

, U

) 7

) d

1 1 9

. 2 _ t n e g A _ S U

l e d o m

_ 8 4